Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
5.39%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ 1.65Close
$ 0.39 - $ 1.81 52-Week Range
Ticker Information
Ticker
LCTXCompany Name
LINEAGE CELL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTLINEAGE CELL THERAPEUTICS INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LCTX - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 588K | 5.39% | $ 10.91M |
| 3/31/2025 | $ 624K | 6.53% | $ 9.56M |
| 12/31/2024 | $ 565K | 5.95% | $ 9.5M |
| 9/30/2024 | $ 291K | 3.34% | $ 8.72M |
| 6/30/2024 | $ 318K | 5.14% | $ 6.19M |
| 3/31/2024 | $ 524K | 6.55% | $ 8M |
| 12/31/2023 | $ 674K | 7.53% | $ 8.95M |
| 9/30/2023 | $ 567K | 6.46% | $ 8.77M |
| 6/30/2023 | $ 714K | 6.78% | $ 10.52M |
| 3/31/2023 | $ 555K | 4.68% | $ 11.85M |
Key Performance Insights, Last 5 Years
- LINEAGE CELL THERAPEUTICS INC's latest trailing twelve months (TTM) CapEx % stands at 0%.
- Over the past 5 years, LINEAGE CELL THERAPEUTICS INC's average CapEx % has been 5.21%.
- The median CapEx % for LINEAGE CELL THERAPEUTICS INC during this period was 5.39%
- LINEAGE CELL THERAPEUTICS INC reached its highest CapEx % over the past 5 years at 8.26%.
- The lowest CapEx % recorded by LINEAGE CELL THERAPEUTICS INC in the same timeframe 2.25%
LINEAGE CELL THERAPEUTICS INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for LINEAGE CELL THERAPEUTICS INC is calculated as follows: CapEx [ $ -53K ] / Revenues [ $ 2.71M ]
(=) CapEx % [ 0% ] LCTX - Capital Expenditures Margin, Last 5 years
2.25%
Minimum
Dec 31, 2020
8.26%
Maximum
Jun 30, 2021
5.21%
Average
5.39%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.04% |
| average | 3.46% |
| median | 2.43% |
| std | 3.27% |